Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.
Notable Penumbra Insider Trades $3.8M In Company Stock
Adam Elsesser, CEO And President at Penumbra (NYSE:PEN), made a large buy and sell of company shares on October 11, according to a new SEC filing.
CEO And President Of Penumbra Trades $4.18 Million In Company Stock
Adam Elsesser, CEO And President at Penumbra (NYSE:PEN), made a large buy and sell of company shares on September 13, according to a new SEC filing.
Truist Securities Initiates Coverage On Penumbra with Buy Rating, Announces Price Target of $350
Truist Securities initiates coverage on Penumbra (NYSE:PEN) with a Buy rating and announces Price Target of $350.
Penumbra Q2 Earnings Beat Estimates; Raises FY21 Sales Outlook
Penumbra Inc (NYSE:PEN) reported Q2 sales of $184.3 million, an increase of 75.3% Y/Y, or 72.7% on a constant currency…
BTIG Maintains Buy on Penumbra, Raises Price Target to $308
BTIG analyst Ryan Zimmerman maintains Penumbra (NYSE:PEN) with a Buy and raises the price target from $299 to $308.
Penumbra: Q2 Earnings Insights
Shares of Penumbra (NYSE:PEN) rose in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share increased 170.00% over the past year to $0.21, which beat the estimate of $0.17.
Penumbra Raises FY21 Sales Guidance From $695M-$705M To $720M-$730M vs $702.42M Est.
The Company is increasing its guidance for 2021 total revenue to be in the range of $720 million to $730 million, which represents 28% to 30% growth over 2020 revenue